| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 5 | -804K | 100% | $0.78 | -$629K |
| Net | -5 | -804K | -100% | -$629K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Paula Ragan | President and CEO, Director | $675K | -$247K | -26.8% | Mar 11, 2024 |
| Arthur Taveras | Chief Scientific Officer | $207K | -$62.8K | -23.3% | Mar 11, 2024 |
| Mary DiBiase | Chief Operating Officer | $190K | -$68.5K | -26.5% | Sep 9, 2024 |
| Murray Stewart | Director | $169K | Jun 10, 2024 | ||
| Derek Meisner | Chief Legal Officer | $131K | Aug 17, 2022 | ||
| Keith Woods | Director | $119K | Jun 10, 2024 | ||
| Michael S. Wyzga | Director | $107K | Jun 10, 2024 | ||
| Diego Cadavid | Chief Medical Officer | $93.7K | Mar 1, 2022 | ||
| Francoise de Craecker | Director | $85.2K | Jun 10, 2024 | ||
| Gary Bridger | Director | $85.2K | Jun 10, 2024 | ||
| William Aliski | Director | $85.2K | Jun 10, 2024 | ||
| D. W. J. Mcgirr | Director | $85.2K | Jun 10, 2024 | ||
| Alison Frances Lawton | Director | $85.2K | Jun 10, 2024 | ||
| Mark Baldry | Chief Commercial Officer | $22.2K | -$7.49K | -25.2% | Feb 13, 2024 |
| Adam S. Mostafa | Chief Financial Officer | $0 | -$243K | -100% | Mar 11, 2024 |
| Rene Russo | Director | Jun 2, 2021 | |||
| Christophe Arbet-Engels | Chief Medical Officer | Feb 13, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|